Papers/PMID:41214650
Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.
BMC medicine2025The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
lycopene — decreases prostate cancer incidence
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“Participants in the highest quartile of lycopene intake displayed a significant 54% lower risk of prostate cancer compared to the lowest quartile (HR: 0.46; 95% CI: 0.23–0.95, p-trend = 0.035) in the fully adjusted model (Table 2, Fig. 1).”
Quoted verbatim from Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.. - Study
- cohort
- Population
- Men aged 55-80 years at high cardiovascular risk from the PREDIMED trial; highest versus lowest quartile of cumulative dietary lycopene intake, fully adjusted model
Effect 0.46 hazard ratio, 95% CI 0.23 to 0.95
Lycopene intake and prostate cancer risk in men at high cardiovascular risk: a prospective cohort study.2025PMID:41214650Permalink